FDA Approves Anjeso
FDA Approves Anjeso (meloxicam injection) for the Management of Moderate to Severe Pain MALVERN, Pa., Feb. 20, 2020 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on…
Patient’s place of residence matters when choosing cost-effective anticoagulation therapy
Appropriately selected anticoagulation therapy can help to reduce the medical costs of patients suffering from atrial fibrillation. A new study from the University of Eastern Finland shows that direct oral…
Research: Chloroquine makes tuberculosis bacteria more susceptible to other antimalarial drugs
A team of researchers at the Indian Institute of Science and the Tata Institute of Fundamental Research, both in India, have found that the antimalarial drug chloroquine can make the…
Resistance to antibiotics doubles in 20 years, new study finds
Resistance to commonly-used antibiotics for treating harmful bacteria related to a variety of stomach conditions has more than doubled in 20 years, new research presented today at UEG Week Barcelona…
Postop opioid Rx sevenfold higher in U.S., Canada versus Sweden
(HealthDay)—Patients in the United States and Canada receive prescription opioids after surgeries at a rate that is approximately seven times higher than the rate in Sweden, according to a study…
Johnson & Johnson must pay $8 bn over drug side effect: jury
A Pennsylvania jury ruled Tuesday that US pharmaceutical giant Johnson & Johnson must pay $8 billion in damages and interest for failing to warn that a psychiatric drug could cause…
Purdue Pharma begins Chapter 11 bankruptcy journey
Purdue Pharma gets its day in court Tuesday after the OxyContin maker filed for bankruptcy and negotiated a potential multi-billion dollar settlement to resolve thousands of lawsuits. An initial hearing…
Pear Therapeutics CEO explains app for addiction treatment
Smartphone apps have transformed the way we read the news, hail rides and connect with friends and family. Pear Therapeutics aims to leverage that technology to enhance treatment for patients…
Study validates guidelines on treating patients with an underactive thyroid
A study led by the University of Birmingham provides strong support for current recommendations on treating patients with an underactive thyroid and validates latest UK and US guidelines, say researchers.…
Research explores the use of new psychoactive substances by young people
A research study into New Psychoactive Substances (NPS)—formerly referred to as ‘legal highs’—provides new evidence about why young people were attracted to the drugs, and the health and social risks…